Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2003
06/05/2003WO2002079395A9 Carotenoid biosynthesis
06/05/2003WO2002077261A3 Human potassium channel
06/05/2003WO2002070704A3 Adipocyte complement related protein zacrp11
06/05/2003WO2002070542A3 Band 3 antigenic peptides, malaria polypeptides and uses thereof
06/05/2003WO2002070002A3 Methods for regulation of immune responses to conditions involving mediator-induced pathology
06/05/2003WO2002064157A9 Localized myocardial injection method for treating ischemic myocardium
06/05/2003WO2002062841A3 Secreted proteins
06/05/2003WO2002060932A3 A serpin in bifidobacteria
06/05/2003WO2002059350A3 Use of sialyltransferases for diagnosing and treating tumorous diseases
06/05/2003WO2002059307A3 Human ltrpc7 proteins, nucleic acid molecules encoding them, and uses thereof
06/05/2003WO2002055684A3 Synthetic proteins containing a protein transduction domain
06/05/2003WO2002048351A3 A method for in vitro molecular evolution of protein function
06/05/2003WO2002046420A3 Nebulin-related protein
06/05/2003WO2002046398A3 Nucleic acid separation using immobilized metal affinity chromatography
06/05/2003WO2002046230A3 G-protein coupled receptors
06/05/2003WO2002042479A3 Polynucleotides encoding defense response proteins
06/05/2003WO2002042330A3 Cystoskeleton-associated proteins
06/05/2003WO2002040673A3 Compositions and methods relating to lung specific genes and proteins
06/05/2003WO2002036620A3 Ets-transcription factor related compound specific promoter and transactivators thereof
06/05/2003WO2002034942A3 Nucleic acid amplification-based methods for the determination of a methylation profile and reagents therefor
06/05/2003WO2002030965A3 Nucleic acids encoding stichodactylidae chromoproteins
06/05/2003WO2002028898A3 Regulation of human secretin receptor-like gpcr
06/05/2003WO2002022866A3 Method and sampling kit for analysing material containing nucleic acid
06/05/2003WO2002018633A3 Determination of the ability of patients to respond to tumour treatment
06/05/2003WO2002014478A3 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
06/05/2003WO2002007754A3 New use
06/05/2003WO2001079540A3 Methods for measuring drug resistance
06/05/2003WO2001064899A9 Nucleotide sequences encoding proteins that take part in the biosynthesis of l-serine, improved method for microbially producing l-serine, and genetically modified microorganism suitable for use in said method
06/05/2003US20030106108 Genetic transformation method for zoysiagrass
06/05/2003US20030106107 Genes encoding plant transcription factors
06/05/2003US20030106106 Flower organ-specific gene and its promoter sequence
06/05/2003US20030106105 Promoter expressed specifically in the cells of plant roots, recombinant vectors and host cells comprising same and transgenic plants obtained
06/05/2003US20030106104 Antiapoptosis; antisense agents; regulation of seed aging in tomatoes; stress resistance; prolonged viability and shelf-life
06/05/2003US20030106103 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
06/05/2003US20030106102 Antiapoptosis; antisense agents; regulation of seed aging in tomatoes; stress resistance; prolonged viability and shelf-life
06/05/2003US20030106101 Antiapoptosis; antisense agents; regulation of seed aging in tomatoes; stress resistance; prolonged viability and shelf-life
06/05/2003US20030106100 DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules
06/05/2003US20030106098 Uridine diphosphate pyrophosphorylase and sucrose synthetase; for redistribution of carbohydrates(glucose) from photosynthetic cells
06/05/2003US20030106097 Hydrolases; insect/disease resistant plants; controlling cellulose concentration during cell wall deposition
06/05/2003US20030106096 Phosphonate metabolizing plants
06/05/2003US20030106095 Glucocerebrosidases; galactosidases; treatment for Gaucher's disease
06/05/2003US20030106094 Disease and insect resistant plants; biological pest control
06/05/2003US20030106093 Coleoptera resistant plants; biological pest control
06/05/2003US20030106092 Endoglucanase gene promoter upregulated by nematodes
06/05/2003US20030106090 Materials and methods for the alteration of enzyme and acetyl CoA levels in plants
06/05/2003US20030106089 Cotton fiber transcriptional factors
06/05/2003US20030106088 Transduction for expression of heterologous proteins in phloem; disease resistant plants; cry proteins; bactericides
06/05/2003US20030106085 Disruption of the prostaglandin E synthase 2 gene
06/05/2003US20030106083 Transgenic mice containing RPTPB tyrosine phosphatase gene disruptions
06/05/2003US20030106082 Transgenic stem cells, formed by dissociating blastomeres, are cultured, impregnated within surrogate; animals models; gene therapy
06/05/2003US20030106081 Transferring dipolid nucleus arrested oocyte in metaphase of meiosis for regeneration of animals embryos/cloning
06/05/2003US20030106080 PTTG knockout rodent as a model to study mechanisms for various physiological phenomena, including diabetes
06/05/2003US20030106079 Immunologically defective rat cells; tumorigenesis
06/05/2003US20030106077 Transfection of noncircular vector into stem cell genome by way of homologous recombination; gene therapy
06/05/2003US20030106075 Novel gene encoding organic anion transporter
06/05/2003US20030106073 Formylpeptide chemoattractant receptors(fpr-rs4); g-protein coupled receptors; antiepileptic agents
06/05/2003US20030105615 Method and a system for predicting protein functional site, a method for improving protein function, and a function-modified protein
06/05/2003US20030105593 Selection of target segments within target genes using a correspondence regime between different triplets of three bases and the three possible positions of a triplet within a nine-base site; A computer program product
06/05/2003US20030105320 Immobilized fluorescent/luminescent probes; detection of amplicons; transcription associated amplification; polymerases
06/05/2003US20030105319 Bacillus endotoxin for controlling moths; cry proteins
06/05/2003US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter
06/05/2003US20030105314 Genetic typing of the human cytochrome P450 2A6 gene and related materials and methods
06/05/2003US20030105313 Disintegrin-like and Metalloprotease with Thrombospondin type 1 motif; antiarthritic agents
06/05/2003US20030105311 Oligonucleotides having A-DNA form and B-DNA form conformational geometry
06/05/2003US20030105310 Gram negative bacteria for detecting and isolating random amino acid sequences from ricketsia ricketsii; in situ mutagenesis; vaccine delivery; tumor diagnosis and targeting
06/05/2003US20030105308 Polymerases; gene expression inhibition; gene therapy
06/05/2003US20030105304 Metal binding proteins and associated methods
06/05/2003US20030105296 Mammalian cytokine-like factor 7
06/05/2003US20030105295 Antagonists of interleukin-15
06/05/2003US20030105293 Human circulating cytokine cc-1
06/05/2003US20030105292 Continously induced g-protein coupled receptors; membrane binding assays
06/05/2003US20030105286 Comprises pseudo-isocytosine and pseudo-uracil for increasing binding affinity to DNA/RNA strands
06/05/2003US20030105285 Odorant receptors
06/05/2003US20030105284 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
06/05/2003US20030105283 Antigenic protein originating in malassezia
06/05/2003US20030105277 Tat transport proteins; antiproliferative agents; antitumor agents
06/05/2003US20030105058 CD44-like protein
06/05/2003US20030105054 For eliciting an immune response and enhancing current therapeutic modalities for the treatment of cancer; stimulates T cell proliferation
06/05/2003US20030105052 Oligoribonucleotide derivatives for specific inhibition of gene expression
06/05/2003US20030105051 Nucleic acid treatment of diseases or conditions related to levels of HER2
06/05/2003US20030105050 Disorders caused by overproduction of collagen fibres, for example, liver cirrhosis, kidney, liver and heart fibrosis, scleroderma, hypertrophic scars and keloids
06/05/2003US20030105048 For in vitro, in vivo or ex vivo transfer of nucleic acids into cells or for the visualization of the nucleic acids administered, by fluorescence
06/05/2003US20030105046 Therapy of amyotrophic lateral sclerosis and head trauma injury by inhibiting interleukin converting enzyme (ICE) by gene therapy
06/05/2003US20030105045 Artificial transcriptional factors and methods of use
06/05/2003US20030105044 Antisense modulation of matrix metalloproteinase 1 expression
06/05/2003US20030105043 Introducing into the cell a ribozyme that inhibits metallothionein expression, wherein the ribozyme comprises a nucleotide sequence for inducing apoptosis in a human cancer cell
06/05/2003US20030105042 For therapy or prophylaxis of hypercholesterolemia and cancer
06/05/2003US20030105041 Antisense modulation of SHH expression
06/05/2003US20030105040 Antisense modulation of inhibitor-kappa B-R expression
06/05/2003US20030105039 Introducing into eukaryotic cell recombinase and single-stranded targeting polynucleotides which are complementary and each having a homology clamp that corresponds to or is complementary to preselected target DNA
06/05/2003US20030105038 Antisense modulation of CREB expression
06/05/2003US20030105037 Antisense modulation of inhibitor-kappa B kinase-gamma expression
06/05/2003US20030105036 Antisense Inhibition of vascular endothelial growth factor receptor-1 expression
06/05/2003US20030105035 Administering synthetic, oligonucleotide, antibody that binds to epidermal growth factor receptor or a cytotoxic agent selected from taxanes, platinum-derived agents, and topoisomeraseII-selective drugs for inhibiting proliferation
06/05/2003US20030105024 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
06/05/2003US20030105018 Using vascular endothelial growth factor (VEGF) and homologues for the manufacture of a medicament to treat neuron disorders
06/05/2003US20030105016 Therapy and prophylaxis of lesion of the vaginal, cervical, or uterine epithelium of a mammal by administering intestinal trefoil peptide
06/05/2003US20030104978 A polypeptide encoded by nucleic acid constructs; recombinant host cell, transgenic animal, transgenic plant; treating blood bleeding, hemostasis
06/05/2003US20030104975 Useful for identification of compounds that induce or inhibit the recruitment of the p160 family cofactors, especially TIF-2 and/ or SRCs cofactors (Translation initiation factor-2 and steroid receptor cofactors)
06/05/2003US20030104972 Recombinant expression
1 ... 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 ... 4023